Predictive factors associated with invasive lobular breast cancer after neoadjuvant chemotherapy

被引:0
|
作者
Julian, T. B.
Anderson, S.
Fourchotte, V.
Zieger, S.
Mamounas, E.
Bear, H.
Costantino, J.
Wolmark, N.
机构
[1] NSABP, Ctr Biostat, Pittsburgh, PA USA
[2] Aultman Hosp, Canton, OH USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
[4] Operat Ctr & Allegheny Gen Hosp, NSABP, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:17 / 17
页数:1
相关论文
共 50 条
  • [31] Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation
    Boughey, Judy C.
    Wagner, Jamie
    Garrett, Betsy J.
    Harker, Lori
    Middleton, Lavinia P.
    Babiera, Gildy V.
    Meric-Bernstam, Funda
    Lucci, Anthony
    Hunt, Kelly K.
    Bedrosian, Isabelle
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (06) : 1606 - 1611
  • [32] Predictive factors associated with involved margins in breast cancer treated with neoadjuvant chemotherapy followed by breast-conserving therapy
    Davoine, Elise
    Dion, Ludivine
    Timoh, Krystel Nyangoh
    Beraud, Eugenie
    Tas, Patrick
    Tavenard, Aude
    Laviolle, Bruno
    Perrin, Christophe
    Foucher, Fabrice
    Leveque, Jean
    Lavoue, Vincent
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2019, 48 (07) : 467 - 472
  • [33] Identification of predictive biomarkers for neoadjuvant chemotherapy response in invasive breast cancer Latino patients
    Guevara-Nieto, Hedda Michelle
    Parra-Medina, Rafael
    Mejia-Henao, Juan Carlos
    Lopez-Correa, Patricia Eugenia
    Guio-Avila, Jose Ismael
    Diaz-Casas, Sandra
    Garai, Jone
    Zabaleta, Jovanny
    Lopez-Kleine, Liliana
    Combita, Alba Lucia
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [34] A high mitotic score in breast cancer after neoadjuvant chemotherapy is predictive of outcome and associated with a distinct morphology
    Angulo, Karen R. Arispe
    Jawa, Zeeshan
    Visotcky, Alexis
    Majidi, Shadie S.
    Chitambar, Christopher R.
    Jorns, Julie M.
    [J]. HISTOPATHOLOGY, 2020, 76 (05) : 661 - 670
  • [35] Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer
    Ishikawa, Takashi
    Shimizu, Daisuke
    Sasaki, Takashi
    Morita, Satoshi
    Tanabe, Mikiko
    Ota, Ikuko
    Kawachi, Kae
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    [J]. CANCER RESEARCH, 2011, 71
  • [36] Predictive Factors of Response to Neoadjuvant Chemotherapy in Hormone Receptor Positive Breast Cancer
    Lai, L.
    Ottesen, R.
    Niland, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S62 - S63
  • [37] Factors associated with mastectomy in women with small residual tumour after neoadjuvant chemotherapy for breast cancer
    Bernell, E.
    Duinmeijer, A.
    Altena, R.
    Foukakis, T.
    Fredholm, H.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S54 - S54
  • [38] Pathological complete response and associated factors in breast cancer after neoadjuvant chemotherapy: A retrospective study
    Gundogdu, Adnan
    Ulusahin, Mehmet
    Cekic, Arif Burak
    Kazaz, Seher Nazli
    Guner, Ali
    [J]. TURKISH JOURNAL OF SURGERY, 2024, 40 (01) : 73 - 81
  • [39] Accuracy of MRI after neoadjuvant therapy for invasive lobular carcinoma of the breast
    Fahrner-Scott, K. E.
    Wong, J. M.
    Piper, M.
    Ewing, C.
    Alvarado, M.
    Esserman, L. J.
    Hylton, N.
    Mukhtar, R. A.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [40] Discussion of: Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Sener, Stephen
    Tsung, Karen
    [J]. AMERICAN JOURNAL OF SURGERY, 2018, 215 (03): : 513 - 514